Merit Medical Systems Inc.

Merit Medical Systems manufactures and markets proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. The company conducts its business through two segments: Cardiovascular, which includes its Peripheral Intervention, Cardiac Intervention, Cardiovascular and Critical Care, Interventional Oncology and Spine and Breast Cancer Localization and Guidance product groups; and Endoscopy, which provides non-vascular stents to treat gastrointestinal and pulmonary disease including AERO?, AEROmini? and AERO DV? Fully Covered Tracheobronchial Stents and Alimaxx-B? Biliary Stent Systems.
  • TickerMMSI
  • ISINUS5898891040
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States
 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce Second Quarter Results on July 29, 2...

Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended June 30, 2021, after the close of the stock market on Thursday, July 29, 2021. Merit will hold its investor conference call (confe...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce First Quarter Results on April 29, 2...

Merit Medical Systems to Announce First Quarter Results on April 29, 2021 SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, April 29, 2021. Merit will hold its investor conference ca...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical to Present at 20th Annual Needham Healthcare Conference

Merit Medical to Present at 20th Annual Needham Healthcare Conference SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. On Thursday, April 15, at 2:15 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Mer...

MMSI Merit Medical S... (Health Care)

An unfavourable environment weighs on MERIT MEDICAL SYSTEM, which sees...

The independent financial analyst theScreener just requalified the general evaluation of MERIT MEDICAL SYSTEM (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 5, 2021, the closing price was USD 55.04 and its target price was estimated at USD 45.73.

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Reports Results For Fourth Quarter and Year Ended Decemb...

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenueQ4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019Q4 2020 non-GAAP EPS* of $0.54, compared to $0.40 in Q4 2019 *  Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A ...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce Second Quarter Results on July 29, 2...

Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended June 30, 2021, after the close of the stock market on Thursday, July 29, 2021. Merit will hold its investor conference call (confe...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce First Quarter Results on April 29, 2...

Merit Medical Systems to Announce First Quarter Results on April 29, 2021 SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, April 29, 2021. Merit will hold its investor conference ca...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical to Present at 20th Annual Needham Healthcare Conference

Merit Medical to Present at 20th Annual Needham Healthcare Conference SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. On Thursday, April 15, at 2:15 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Mer...

MMSI Merit Medical S... (Health Care)

An unfavourable environment weighs on MERIT MEDICAL SYSTEM, which sees...

The independent financial analyst theScreener just requalified the general evaluation of MERIT MEDICAL SYSTEM (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 5, 2021, the closing price was USD 55.04 and its target price was estimated at USD 45.73.

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Reports Results For Fourth Quarter and Year Ended Decemb...

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenueQ4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019Q4 2020 non-GAAP EPS* of $0.54, compared to $0.40 in Q4 2019 *  Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A ...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce Second Quarter Results on July 29, 2...

Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended June 30, 2021, after the close of the stock market on Thursday, July 29, 2021. Merit will hold its investor conference call (confe...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce First Quarter Results on April 29, 2...

Merit Medical Systems to Announce First Quarter Results on April 29, 2021 SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, April 29, 2021. Merit will hold its investor conference ca...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical to Present at 20th Annual Needham Healthcare Conference

Merit Medical to Present at 20th Annual Needham Healthcare Conference SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. On Thursday, April 15, at 2:15 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Mer...

MMSI Merit Medical S... (Health Care)

An unfavourable environment weighs on MERIT MEDICAL SYSTEM, which sees...

The independent financial analyst theScreener just requalified the general evaluation of MERIT MEDICAL SYSTEM (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 5, 2021, the closing price was USD 55.04 and its target price was estimated at USD 45.73.

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Reports Results For Fourth Quarter and Year Ended Decemb...

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenueQ4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019Q4 2020 non-GAAP EPS* of $0.54, compared to $0.40 in Q4 2019 *  Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A ...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce Second Quarter Results on July 29, 2...

Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended June 30, 2021, after the close of the stock market on Thursday, July 29, 2021. Merit will hold its investor conference call (confe...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce First Quarter Results on April 29, 2...

Merit Medical Systems to Announce First Quarter Results on April 29, 2021 SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, April 29, 2021. Merit will hold its investor conference ca...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical to Present at 20th Annual Needham Healthcare Conference

Merit Medical to Present at 20th Annual Needham Healthcare Conference SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. On Thursday, April 15, at 2:15 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Mer...

MMSI Merit Medical S... (Health Care)

An unfavourable environment weighs on MERIT MEDICAL SYSTEM, which sees...

The independent financial analyst theScreener just requalified the general evaluation of MERIT MEDICAL SYSTEM (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 5, 2021, the closing price was USD 55.04 and its target price was estimated at USD 45.73.

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Reports Results For Fourth Quarter and Year Ended Decemb...

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenueQ4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019Q4 2020 non-GAAP EPS* of $0.54, compared to $0.40 in Q4 2019 *  Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A ...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce Second Quarter Results on July 29, 2...

Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended June 30, 2021, after the close of the stock market on Thursday, July 29, 2021. Merit will hold its investor conference call (confe...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Systems to Announce First Quarter Results on April 29, 2...

Merit Medical Systems to Announce First Quarter Results on April 29, 2021 SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, April 29, 2021. Merit will hold its investor conference ca...

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical to Present at 20th Annual Needham Healthcare Conference

Merit Medical to Present at 20th Annual Needham Healthcare Conference SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. On Thursday, April 15, at 2:15 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Mer...

MMSI Merit Medical S... (Health Care)

An unfavourable environment weighs on MERIT MEDICAL SYSTEM, which sees...

The independent financial analyst theScreener just requalified the general evaluation of MERIT MEDICAL SYSTEM (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 5, 2021, the closing price was USD 55.04 and its target price was estimated at USD 45.73.

 PRESS RELEASE
MMSI Merit Medical S... (Health Care)

Merit Medical Reports Results For Fourth Quarter and Year Ended Decemb...

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenueQ4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019Q4 2020 non-GAAP EPS* of $0.54, compared to $0.40 in Q4 2019 *  Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch